Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Bcl-2–associated athanogene 3 protects the heart from ischemia/reperfusion injury
Feifei Su, Valerie D. Myers, Tijana Knezevic, JuFang Wang, Erhe Gao, Muniswamy Madesh, Farzaneh G. Tahrir, Manish K. Gupta, Jennifer Gordon, Joseph Rabinowitz, Frederick V. Ramsey, Douglas G. Tilley, Kamel Khalili, Joseph Y. Cheung, Arthur M. Feldman
Feifei Su, Valerie D. Myers, Tijana Knezevic, JuFang Wang, Erhe Gao, Muniswamy Madesh, Farzaneh G. Tahrir, Manish K. Gupta, Jennifer Gordon, Joseph Rabinowitz, Frederick V. Ramsey, Douglas G. Tilley, Kamel Khalili, Joseph Y. Cheung, Arthur M. Feldman
View: Text | PDF
Research Article Cardiology Cell biology

Bcl-2–associated athanogene 3 protects the heart from ischemia/reperfusion injury

  • Text
  • PDF
Abstract

Bcl-2–associated athanogene 3 (BAG3) is an evolutionarily conserved protein expressed at high levels in the heart and the vasculature and in many cancers. While altered BAG3 expression has been associated with cardiac dysfunction, its role in ischemia/reperfusion (I/R) is unknown. To test the hypothesis that BAG3 protects the heart from reperfusion injury, in vivo cardiac function was measured in hearts infected with either recombinant adeno-associated virus serotype 9–expressing (rAAV9-expressing) BAG3 or GFP and subjected to I/R. To elucidate molecular mechanisms by which BAG3 protects against I/R injury, neonatal mouse ventricular cardiomyocytes (NMVCs) in which BAG3 levels were modified by adenovirus expressing (Ad-expressing) BAG3 or siBAG3 were exposed to hypoxia/reoxygenation (H/R). H/R significantly reduced NMVC BAG3 levels, which were associated with enhanced expression of apoptosis markers, decreased expression of autophagy markers, and reduced autophagy flux. The deleterious effects of H/R on apoptosis and autophagy were recapitulated by knockdown of BAG3 with Ad-siBAG3 and were rescued by Ad-BAG3. In vivo, treatment of mice with rAAV9-BAG3 prior to I/R significantly decreased infarct size and improved left ventricular function when compared with mice receiving rAAV9-GFP and improved markers of autophagy and apoptosis. These findings suggest that BAG3 may provide a therapeutic target in patients undergoing reperfusion after myocardial infarction.

Authors

Feifei Su, Valerie D. Myers, Tijana Knezevic, JuFang Wang, Erhe Gao, Muniswamy Madesh, Farzaneh G. Tahrir, Manish K. Gupta, Jennifer Gordon, Joseph Rabinowitz, Frederick V. Ramsey, Douglas G. Tilley, Kamel Khalili, Joseph Y. Cheung, Arthur M. Feldman

×

Figure 4

BAG3 knockdown and hypoxia/reoxygenation increase apoptosis in neonatal mouse ventricular cardiomyocytes, whereas overexpression of BAG3 mitigates the increase in apoptosis after hypoxia/reoxygenation.

Options: View larger image (or click on image) Download as PowerPoint
BAG3 knockdown and hypoxia/reoxygenation increase apoptosis in neonatal ...
Neonatal mouse ventricular cardiomyocytes (NMVCs) were infected with an adenovirus driving the expression of BAG3 (Ad-BAG3), GFP, or a siRNA for BAG3 (Ad-siBAG3) and then cultured under hypoxic conditions (5% CO2 and 95% nitrogen at 3 l/min) in the absence of glucose for 14 hours at 37°C followed by reoxygenation for 4 hours with 5% CO2 and 95% humidified air in medium containing glucose (hypoxia/reoxygenation [H/R]) or under normoxic (Control) condition (5% CO2 and 95% humidified air). The cells were then stained with DAPI to identify nuclei; TUNEL to identify DNA fragments, a characteristic feature of apoptosis; or probed with α-actinin to identify cardiomyocytes. Three independent cultures of NMVCs were exposed to either hypoxia/reoxygenation or normoxia (control) plus or minus infection with Ad-BAG3 or Ad-siBAG3. Each experiment was then repeated 3 times in order to have n = 9 for each intervention. Five fields were then counted for the number of TUNEL-positive nuclei in α-sarcomeric actinin-positive cells from each experiment using a fluorescent microscope and a ×20 objective (original magnification, ×200) (n = 15). (A) Representative confocal microscopic images. (B) Data are presented as mean ± SEM for continuous variables. Two-way ANOVA with Bonferroni multiple comparisons adjustments were used to assess differences across the 4 investigational groups. The percentage of TUNEL-positive nuclei increased significantly when BAG3 was knocked down and after H/R whereas overexpression of BAG3 attenuated the effects of H/R.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts